✦ LIBER ✦

Therapeutic vaccines against HIV and cancers

✍ Scribed by Marc Girard; Betty Dodet; Marissa Vicari

Book ID: 117431196
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 24 KB
Volume: 20
Category: Article
ISSN: 0264-410X
DOI: 10.1016/s0264-410x(02)00487-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

NKT cell adjuvants in therapeutic vaccin

NKT cell adjuvants in therapeutic vaccines against hematological cancers

✍ Mattarollo, Stephen R.; Smyth, Mark J 📂 Article 📅 2013 🏛 Landes Bioscience 🌐 English ⚖ 409 KB

Science and Society: Therapeutic vaccine

Science and Society: Therapeutic vaccines against HIV need international partnerships

✍ Autran, Brigitte; Debré,, Patrice; Walker, Bruce; Katlama, Christine 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 205 KB

Therapeutic vaccines against melanoma an

Therapeutic vaccines against melanoma and colorectal cancer

✍ Jim Tartaglia; Marie-Claude Bonnet; Neil Berinstein; Brian Barber; Michel Klein; 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 69 KB

HIV-1 Therapeutic Vaccines

✍ S. Kinloch-de Loes; B. Autran 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 132 KB

Dendritic cells as therapeutic vaccines

Dendritic cells as therapeutic vaccines against cancer

✍ Banchereau, Jacques; Palucka, A. Karolina 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 452 KB

Dendritic-cell-based therapeutic vaccina

Dendritic-cell-based therapeutic vaccination against cancer

✍ Frank O Nestle; Arpad Farkas; Curdin Conrad 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 133 KB

Early clinical trials, in which over 1000 cancer patients received dendritic cell (DC) vaccines, tested different vaccine preparations, but they did not always induce sufficient acquired immunity or meet the expected level of tumor regressions. Current studies aim to improve the DC vaccine approach